BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 6469748)

  • 1. Glutathione depletion in tissues after administration of buthionine sulphoximine.
    Minchinton AI; Rojas A; Smith KA; Soranson JA; Shrieve DC; Jones NR; Bremner JC
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1261-4. PubMed ID: 6469748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depletion of tumour versus normal tissue glutathione by buthionine sulfoximine.
    Lee FY; Allalunis-Turner MJ; Siemann DW
    Br J Cancer; 1987 Jul; 56(1):33-8. PubMed ID: 3620316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depletion of tumour glutathione in vivo by buthionine sulphoximine: modulation by the rate of cellular proliferation and inhibition of cancer growth.
    Terradez P; Asensi M; Lasso de la Vega MC; Puertes IR; ViƱa J; Estrela JM
    Biochem J; 1993 Jun; 292 ( Pt 2)(Pt 2):477-83. PubMed ID: 8503882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R; Miners JO
    Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of glutathione depletion by buthionine sulphoximine on 1-cyano-3,4-epithiobutane toxicity.
    VanSteenhouse JL; Fettman MJ; Gould DH
    Food Chem Toxicol; 1991 Mar; 29(3):153-7. PubMed ID: 2032656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depletion of glutathione in vivo as a method of improving the therapeutic ratio of misonidazole and SR 2508.
    Yu NY; Brown JM
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1265-9. PubMed ID: 6236185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of misonidazole radiosensitization by buthionine sulphoximine.
    Rojas A; Smith KA; Soranson JA; Minchinton AI; Middleton RW; Denekamp J
    Radiother Oncol; 1984 Dec; 2(4):325-32. PubMed ID: 6522642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC; Henderson BW
    J Natl Cancer Inst; 1986 Aug; 77(2):505-10. PubMed ID: 3461211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempted modulation of disulfide antitumor activity in Balb/c mice through glutathione depletion.
    Coshan-Gauthier RK; Kirkpatrick DL
    Exp Cell Biol; 1989; 57(5):273-80. PubMed ID: 2625181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD; Ragsdale SS; Benson JM; Henderson RF
    Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nephrotoxicity of thiabendazole in mice depleted of glutathione by treatment with DL-buthionine sulphoximine.
    Mizutani T; Ito K; Nomura H; Nakanishi K
    Food Chem Toxicol; 1990 Mar; 28(3):169-77. PubMed ID: 2344991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC; Harris JW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular glutathione depletion by diethyl maleate or buthionine sulfoximine: no effect of glutathione depletion on the oxygen enhancement ratio.
    Mitchell JB; Russo A; Biaglow JE; McPherson S
    Radiat Res; 1983 Nov; 96(2):422-8. PubMed ID: 6647769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemosensitization by buthionine sulfoximine in vivo.
    Tsutsui K; Komuro C; Ono K; Nishidai T; Shibamoto Y; Takahashi M; Abe M
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1183-6. PubMed ID: 2427490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
    Gallagher EP; Hasspieler BM; Di Giulio RT
    Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of brain glutathione in preweanling mice by L-buthionine sulfoximine.
    Slivka A; Spina MB; Calvin HI; Cohen G
    J Neurochem; 1988 May; 50(5):1391-3. PubMed ID: 3361302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective depletion of glutathione in rat striatum and substantia nigra by L-buthionine sulfoximine in combination with 2-cyclohexene-1-one.
    Pileblad E; Magnusson T
    Life Sci; 1990; 47(25):2333-42. PubMed ID: 2263161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.